Tronox to close Dutch titanium dioxide plant with 90,000-ton annual capacity

Tronox Holdings plc (NYSE: TROX) ("Tronox" or the "Company"), a global leader in the production of titanium dioxide (TiO2) pigment, announced on March 17 that following a strategic review of its asset portfolio, Tronox has informed its employees in the Netherlands that the Company plans to cease operations at its Botlek, Netherlands, TiO2 pigment manufacturing facility. The facility, which has an annual production capacity of 90,000 tons, is currently idled due to an incident at its chlorine supplier on March 6, 2025, and is not expected to resume production following consultation with the Works Council. Tronox expects this action will not impact its ability to supply customers as the Company will leverage its diversified manufacturing footprint to ensure supply continuity. Approximately 240 permanent employees are impacted by this facility closure.

"Today's announcement is the result of a comprehensive review of our asset portfolio," said John D. Romano, Chief Executive Officer. "Intensified competition from Chinese producers over the past two and a half years has led to persistent global supply imbalances and an increasingly challenging operating environment. The idling of the Botlek facility will allow us to optimize the operations of our remaining facilities and reduce our overall manufacturing costs. Our colleagues at Botlek are an integral part of the Tronox team, and we are committed to supporting them through this difficult transition with assistance from local management and a comprehensive suite of services."

Tronox expects to incur approximately $130 million to $160 million in restructuring and other related charges, primarily over the next 18 months, including $55 million to $65 million in non-cash impairments related to the idling of the Botlek facility. Cost savings are expected to exceed $30 million annually beginning in 2026. The cost savings from the Botlek facility idling are incremental to the previously announced sustainable, run-rate cost improvements of $125 million to $175 million expected to be achieved by the end of 2026. As a result of these planned actions, free cash flow is expected to exceed $50 million for the full year 2025.